文献速递主动脉疾病

择期开放转换与开窗分支腔内修复治疗既往非感染性失败腔内动脉瘤修复的系统综述与Meta分析

Systematic Review and Meta-Analysis of Elective Open Conversion versus Fenestrated and Branched Endovascular Repair for Previous Non-Infected Failed Endovascular Aneurysm Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-09-23

系统综述与Meta分析纳入38项研究共1645例患者,比较择期开放转换(1001例,60.9%)与开窗分支腔内修复(F/B-EVAR,644例,39.1%)治疗既往非感染性失败腔内动脉瘤修复。30天死亡两组相近(开放转换2.3% vs F/B-EVAR 2.4%,p=0.36),F/B-EVAR技术成功率94.1%。18个月随访时开放转换再干预率较低(4.5% vs 26%,p<0.001)、总生存较高(92.5% vs 81.6%,p=0.005),但证据质量总体有限。

要点

  • 择期开放转换与F/B-EVAR治疗失败EVAR的早期结果均似满意。
  • 30天死亡开放转换2.3% vs F/B-EVAR 2.4%,差异无统计学意义(p=0.36)。
  • 18个月再干预开放转换4.5% vs F/B-EVAR 26%,总生存92.5% vs 81.6%。

核心结论

  • 在择期且排除感染的情况下,开放转换与F/B-EVAR治疗失败EVAR的早期结果均似满意。
  • 开放转换术后30天并发症率较高,但随访时似乎与较少的再干预和较好的生存相关。

研究设计与样本

  • 系统综述与Meta分析,检索Embase、MEDLINE和Cochrane Library,方案前瞻性注册于PROSPERO(CRD42023404091),遵循PRISMA指南,采用GRADE评估证据确定性、MINORS工具评估质量。
  • 共纳入38项研究、1645例患者,其中开放转换1001例(60.9%),F/B-EVAR 644例(39.1%)。
  • 对F/B-EVAR和开放转换的结果数据分别合并,采用随机效应模型对比例进行Meta分析,用I2统计量评估异质性。

主要发现

  • 30天死亡开放转换组为2.3%(I2 33%),F/B-EVAR组为2.4%(I2 0%),p=0.36。
  • F/B-EVAR技术成功率为94.1%(I2 23%)。
  • 30天主要全身并发症开放转换组为21.3%(I2 74%),F/B-EVAR组为15.7%(I2 78%),p=0.52。
  • 18个月随访再干预率开放转换组为4.5%(I2 58%),F/B-EVAR组为26%(I2 0%),p<0.001。
  • 18个月随访总生存开放转换组为92.5%(I2 59%),F/B-EVAR组为81.6%(I2 68%),p=0.005。

关键数值与推荐

  • 证据质量总体有限;30天死亡(两组)和F/B-EVAR技术成功的GRADE确定性评为低,其他结局评为极低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据质量总体有限。
  • 30天死亡(两组)和F/B-EVAR技术成功的GRADE确定性评为低,其他结局评为极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate outcomes of patients electively undergoing fenestrated and branched endovascular repair (F/B-EVAR) or open conversion for failed previous non-infected endovascular aneurysm repair (EVAR). DATA SOURCES: Embase, MEDLINE, Cochrane Library. REVIEW METHOD: The protocol was prospectively registered on PROSPERO (CRD42023404091). The review followed the PRISMA guidelines; certainty was assessed through the GRADE and quality through MINORS tools. Outcomes data were pooled separately for F/B-EVAR and open conversion. A random effects meta-analysis of proportions was conducted; heterogeneity was assessed with the I2 statistic. RESULTS: Thirty eight studies were included, for a total of 1 645 patients of whom 1 001 (60.9%) underwent an open conversion and 644 (39.1%) a F/B-EVAR. The quality of evidence was generally limited. GRADE certainty was judged low for 30 day death (in both groups) and F/B-EVAR technical success, and very low for the other outcomes. Pooled 30 day death was 2.3% (I2 33%) in the open conversion group and 2.4% (I2 0%) in the F/B-EVAR conversion group (p = .36). Technical success for F/B-EVAR was 94.1% (I2 23%). The pooled 30 day major systemic complications rate was higher in the open conversion (21.3%; I2 74%) than in the F/B-EVAR (15.7%; I2 78%) group (p = .52). At 18 months follow up, the pooled re-intervention rate was 4.5% (I2 58%) in the open conversion and 26% (I2 0%) in the F/B-EVAR group (p < .001), and overall survival was 92.5% (I2 59%) and 81.6% (I2 68%), respectively (p = .005). CONCLUSION: In the elective setting, and excluding infections, the early results of both open conversion and F/B-EVAR after failed EVAR appear satisfactory. Although open conversion presented with higher complication rates in the first 30 days after surgery, at follow up it seemed to be associated with fewer re-interventions and better survival compared with F/B-EVAR.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Esposito D, Rawashdeh M, Onida S, et al. Systematic Review and Meta-Analysis of Elective Open Conversion versus Fenestrated and Branched Endovascular Repair for Previous Non-Infected Failed Endovascular Aneurysm Repair. Eur J Vasc Endovasc Surg. 2023. PMID: 37748552. doi:10.1016/j.ejvs.2023.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。